drugset / Trial / NCT01705197

This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.

NCT01705197

Phase 3 Completed 195 enrolled JW Pharmaceutical
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of Avanafil in the treatment of erectile dysfunction with moderate to severe in subjects. And, this is to additionally confirm the efficacy and safety after initiating treatment with Avanafil 100mg and later increasing to 200mg, compared with continuing treatment with Avanafile 100mg, in subjects.

Timeline

Start
2012-02
Primary completion
2013-04
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Avanafil Small molecule 100 mg
Comparator Avanafil Small molecule 200 mg

Indications